Cargando…
Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target
Autor principal: | Ceriello, Antonio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909084/ https://www.ncbi.nlm.nih.gov/pubmed/20668158 http://dx.doi.org/10.2337/dc10-0634 |
Ejemplares similares
-
Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010) -
Glucose Variability: Where It Is Important and How to Measure It
por: DeVries, J. Hans
Publicado: (2013) -
Point: Steady Progress and Current Challenges in Clinical Islet Transplantation
por: Mineo, Davide, et al.
Publicado: (2009) -
Glucose Variability
por: Service, F. John
Publicado: (2013) -
Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: Right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users
por: Polonsky, William H., et al.
Publicado: (2013)